Gene Details



Btk and homologs in 4 species are found in 785 GeneSets:


- Entrez   - Ensembl   - GeneNetwork   - STRING   - Allen Brain Atlas   - MGI   - Comparative Toxicogenomics Database  

Select gene sets below using the check boxes, and then add them to a project using the pull down below. You can also create a project using the pull down. To view a set, click on the GeneSetID:GeneSet Description shown in green below.
GS185131: GO:0044699 single-organism process
GS207306: GO:0080134 regulation of response to stress
GS191217: GO:0045087 innate immune response
GS169480: MP:0001876 decreased inflammatory response
GS192507: GO:0006812 cation transport
GS170466: MP:0008211 decreased mature B cell number
GS196653: GO:0001783 B cell apoptotic process
GS175490: HP:0000999 Pyoderma
GS169127: MP:0002445 abnormal mononuclear cell differentiation
GS205510: GO:0001883 purine nucleoside binding
GS171644: HP:0011842 Abnormality of skeletal morphology
GS175930: HP:0000246 Sinusitis
GS189855: GO:0043168 anion binding
GS199676: GO:0008063 Toll signaling pathway
GS168559: MP:0002421 abnormal cell-mediated immunity
GS171546: HP:0003729 Enteroviral dermatomyositis syndrome
GS168327: MP:0008171 abnormal mature B cell morphology
GS175130: HP:0000750 Delayed speech and language development
GS169830: MP:0005384 cellular phenotype
GS193546: GO:0002279 mast cell activation involved in immune response
GS166061: MP:0009332 abnormal splenocyte morphology
GS169733: MP:0002461 increased immunoglobulin level
GS172294: HP:0001510 Growth delay
GS174134: HP:0002012 Abnormality of the abdominal organs
GS184984: GO:0032553 ribonucleotide binding
GS191193: GO:0009607 response to biotic stimulus
GS171928: HP:0100577 Urinary bladder inflammation
GS206251: GO:0016301 kinase activity
GS165858: MP:0005000 abnormal immune tolerance
GS183645: GO:0017076 purine nucleotide binding
GS186548: GO:0035091 phosphatidylinositol binding
GS207674: GO:0002697 regulation of immune effector process
GS170969: HP:0000157 Abnormality of the tongue
GS191019: GO:0034641 cellular nitrogen compound metabolic process
GS168334: MP:0002619 abnormal lymphocyte morphology
GS176107: HP:0000929 Abnormality of the skull
GS187887: GO:0080090 regulation of primary metabolic process
GS165859: MP:0000351 increased cell proliferation
GS203844: GO:0018212 peptidyl-tyrosine modification
GS166858: MP:0000685 abnormal immune system morphology
GS163965: MP:0011182 decreased hematopoietic cell number
GS166749: MP:0002221 abnormal lymph organ size
GS178334: GO:0007267 cell-cell signaling
GS189669: GO:2000112 regulation of cellular macromolecule biosynthetic process
GS163010: MP:0011181 increased hematopoietic cell number
GS176098: HP:0000927 Abnormality of skeletal maturation
GS206108: GO:2001141 regulation of RNA biosynthetic process
GS170586: MP:0004978 decreased B-1 B cell number
GS192017: GO:0006139 nucleobase-containing compound metabolic process
GS196343: GO:0036094 small molecule binding
GS172054: HP:0001507 Growth abnormality
GS184917: GO:0002252 immune effector process
GS177404: GO:0005737 cytoplasm
GS207925: GO:0034645 cellular macromolecule biosynthetic process
GS201251: GO:0044424 intracellular part
GS193238: GO:0031323 regulation of cellular metabolic process
GS203908: GO:0016070 RNA metabolic process
GS168992: MP:0005087 decreased acute inflammation
GS188142: GO:0048856 anatomical structure development
GS177440: GO:0006915 apoptotic process
GS192508: GO:0006811 ion transport
GS207997: GO:0004713 protein tyrosine kinase activity
GS196988: GO:0045595 regulation of cell differentiation
GS165866: MP:0000350 abnormal cell proliferation
GS183543: GO:0051179 localization
GS165419: MP:0002491 decreased IgD level
GS171126: HP:0000022 Abnormality of male internal genitalia
GS174338: HP:0002719 Recurrent infections
GS162953: MP:0002020 increased tumor incidence
GS165744: MP:0008470 abnormal spleen B cell follicle morphology
GS175330: HP:0000031 Epididymitis
GS205500: GO:0071944 cell periphery
GS193414: GO:0044249 cellular biosynthetic process
GS205334: GO:0051090 regulation of sequence-specific DNA binding transcription factor activity
GS163243: MP:0002362 abnormal spleen marginal zone morphology
GS209108: GO:0000166 nucleotide binding
GS194599: GO:0002902 regulation of B cell apoptotic process
GS173614: HP:0002743 Recurrent enteroviral infections
GS167325: MP:0002144 abnormal B cell differentiation
GS191728: GO:0008289 lipid binding
GS163824: MP:0001259 abnormal body weight
GS189547: GO:0002441 histamine secretion involved in inflammatory response
GS192643: GO:0048471 perinuclear region of cytoplasm
GS188652: GO:0001882 nucleoside binding
GS169772: MP:0001844 autoimmune response
GS173557: HP:0005372 Abnormality of B cell physiology
GS175601: HP:0002086 Abnormality of the respiratory system
GS169732: MP:0002462 abnormal granulocyte physiology
GS201799: GO:0032550 purine ribonucleoside binding
GS176203: HP:0000478 Abnormality of the eye
GS188060: GO:0016773 phosphotransferase activity, alcohol group as acceptor
GS193550: GO:0002274 myeloid leukocyte activation
GS194455: GO:0051239 regulation of multicellular organismal process
GS169731: MP:0002463 abnormal neutrophil physiology
GS208131: GO:0045087 innate immune response
GS165414: MP:0002498 abnormal acute inflammation
GS171226: HP:0000812 Abnormal internal genitalia
GS180852: GO:0006954 inflammatory response
GS206237: GO:0042981 regulation of apoptotic process
GS168063: MP:0000313 abnormal cell death
GS167829: MP:0008484 decreased spleen germinal center size
GS194876: GO:0042113 B cell activation
GS174756: HP:0011947 Respiratory tract infection
GS162982: MP:0002357 abnormal spleen white pulp morphology
GS201696: GO:0010941 regulation of cell death
GS175982: HP:0000162 Glossoptosis
GS201367: GO:0019538 protein metabolic process
GS192299: GO:0006793 phosphorus metabolic process
GS208716: GO:2000026 regulation of multicellular organismal development
GS196808: GO:0032501 multicellular organismal process
GS171708: HP:0000359 Abnormality of the inner ear
GS178913: GO:0042221 response to chemical stimulus
GS186744: GO:0043226 organelle
GS182835: GO:0005622 intracellular
GS182703: GO:0051171 regulation of nitrogen compound metabolic process
GS203482: GO:0044093 positive regulation of molecular function
GS177156: GO:0018108 peptidyl-tyrosine phosphorylation
GS186790: GO:0006725 cellular aromatic compound metabolic process
GS197619: GO:0005543 phospholipid binding
GS194111: GO:0097159 organic cyclic compound binding
GS167993: MP:0002403 abnormal pre-B cell morphology
GS171645: HP:0011843 Abnormality of skeletal physiology
GS800: UCSD_CEREBELLUM_Additive_Time_Pattern_4th
GS170110: MP:0003725 increased autoantibody level
GS184448: GO:0044425 membrane part
GS175933: HP:0000245 Abnormality of the sinuses
GS173134: HP:0003095 Septic arthritis
GS166118: MP:0002109 abnormal limb morphology
GS197666: GO:0051249 regulation of lymphocyte activation
GS204871: GO:0002822 regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
GS206742: GO:0043167 ion binding
GS189751: GO:0050794 regulation of cellular process
GS173534: HP:0001877 Abnormality of erythrocytes
GS197268: GO:0070227 lymphocyte apoptotic process
GS187343: GO:0006351 transcription, DNA-dependent
GS207178: GO:0050867 positive regulation of cell activation
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
GS164115: MP:0000222 decreased neutrophil cell number
GS171815: HP:0001574 Abnormality of the integument
GS187175: GO:0045321 leukocyte activation
GS200566: GO:0019724 B cell mediated immunity
GS170791: HP:0010978 Abnormality of immune system physiology
GS181473: GO:0005488 binding
GS167008: MP:0008164 abnormal B-1a B cell morphology
GS175526: HP:0000005 Mode of inheritance
GS180036: GO:0032501 multicellular organismal process
GS196930: GO:0065007 biological regulation
GS200312: GO:0019219 regulation of nucleobase-containing compound metabolic process
GS167631: MP:0005464 abnormal platelet physiology
GS197694: GO:0002460 adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
GS192512: GO:0003824 catalytic activity
GS163230: MP:0008168 decreased B-1a cell number
GS167823: MP:0008482 decreased spleen germinal center number
GS163611: MP:0008783 decreased B cell apoptosis
GS180644: GO:0032549 ribonucleoside binding
GS180826: GO:0005543 phospholipid binding
GS207616: GO:0016020 membrane
GS200569: GO:0019722 calcium-mediated signaling
GS210574: GO:0002712 regulation of B cell mediated immunity
GS127028: Mifepristone interacting genes (MeSH:D015735) in CTD
GS210170: GO:0030097 hemopoiesis
GS169303: MP:0008250 abnormal myeloid leukocyte morphology
GS180229: GO:0005886 plasma membrane
GS169389: MP:0002060 abnormal skin morphology
GS86609: Table S2: Cocaine regulation of gene expression in the OFC: Effects of DeltaFosB and DeltaJunD Table S2a. Genes Significantly Regulated by Chronic Cocaine [DRG] provisional
GS167542: MP:0001790 abnormal immune system physiology
GS204919: GO:0016772 transferase activity, transferring phosphorus-containing groups
GS204746: GO:0080090 regulation of primary metabolic process
GS165428: MP:0005153 abnormal B cell proliferation
GS205321: GO:0031410 cytoplasmic vesicle
GS163601: MP:0002089 abnormal postnatal growth/weight/body size
GS197244: GO:0044237 cellular metabolic process
GS168851: MP:0002451 abnormal macrophage physiology
GS193991: GO:0048731 system development
GS163491: MP:0003304 large intestinal inflammation
GS198456: GO:0019438 aromatic compound biosynthetic process
GS863: Differential expression across development in Sey Pax6 mutants and controls in an inverted-U (downward parabola).
GS163294: MP:0000218 increased leukocyte cell number
GS181667: GO:0019438 aromatic compound biosynthetic process
GS209998: GO:0002758 innate immune response-activating signal transduction
GS128586: Rotarod Baseline Chr# X
GS171558: HP:0000389 Chronic otitis media
GS174948: HP:0100763 Abnormality of the lymphatic system
GS188511: GO:0010468 regulation of gene expression
GS165527: MP:0005378 growth/size phenotype
GS169728: MP:0002467 impaired neutrophil phagocytosis
GS205607: GO:0002768 immune response-regulating cell surface receptor signaling pathway
GS175158: HP:0011747 Abnormality of the anterior pituitary
GS175529: HP:0000001 All
GS165418: MP:0002490 abnormal immunoglobulin level
GS209199: GO:0007165 signal transduction
GS198323: GO:0046872 metal ion binding
GS210285: GO:0071887 leukocyte apoptotic process
GS199781: GO:0043067 regulation of programmed cell death
GS190471: GO:0005829 cytosol
GS185206: GO:0045055 regulated secretory pathway
GS165740: MP:0008474 absent spleen germinal center
GS169767: MP:0002396 abnormal hematopoietic system morphology/development
GS175822: HP:0002090 Pneumonia
GS184447: GO:0044424 intracellular part
GS206737: GO:0043168 anion binding
GS187067: GO:0046879 hormone secretion
GS193236: GO:0031326 regulation of cellular biosynthetic process
GS188577: GO:0000302 response to reactive oxygen species
GS207673: GO:0002694 regulation of leukocyte activation
GS209863: GO:0050896 response to stimulus
GS136739: small testis weight 2 (Smtw2, Published QTL Chr X)
GS204918: GO:0016773 phosphotransferase activity, alcohol group as acceptor
GS169777: MP:0002398 abnormal bone marrow cell morphology/development
GS166513: MP:0008195 abnormal antigen presenting cell morphology
GS165035: MP:0008202 absent B-1 B cells
GS169880: MP:0009676 abnormal hemostasis
GS176021: HP:0010927 Abnormality of divalent inorganic cation homeostasis
GS163080: MP:0010273 increased classified tumor incidence
GS176008: HP:0010701 Abnormal immunoglobulin level
GS191021: GO:0034645 cellular macromolecule biosynthetic process
GS199499: GO:0051171 regulation of nitrogen compound metabolic process
GS177598: GO:0043412 macromolecule modification
GS172422: HP:0012115 Hepatitis
GS203335: GO:0048513 organ development
GS190794: GO:0002349 histamine production involved in inflammatory response
GS186740: GO:0043229 intracellular organelle
GS169409: MP:0004939 abnormal B cell morphology
GS136144: lithogenic gene 4 (Lith4, Published QTL Chr X)
GS163589: MP:0005017 decreased B cell number
GS206414: GO:0002449 lymphocyte mediated immunity
GS208010: GO:0002368 B cell cytokine production
GS197087: GO:0016310 phosphorylation
GS170649: MP:0002346 abnormal lymph node secondary follicle morphology
GS210580: GO:0002718 regulation of cytokine production involved in immune response
GS166250: MP:0008247 abnormal mononuclear cell morphology
GS175806: HP:0001417 X-linked inheritance
GS199538: GO:0018193 peptidyl-amino acid modification
GS182223: GO:0002366 leukocyte activation involved in immune response
GS175786: HP:0001412 Enteroviral hepatitis
GS163854: MP:0000549 absent limbs
GS182234: GO:0036211 protein modification process
GS193015: GO:0003001 generation of a signal involved in cell-cell signaling
GS188506: GO:0010467 gene expression
GS196587: GO:0006468 protein phosphorylation
GS199214: GO:0034130 toll-like receptor 1 signaling pathway
GS164534: MP:0002019 abnormal tumor incidence
GS164799: MP:0008174 decreased follicular B cell number
GS171146: HP:0009714 Abnormality of the epididymis
GS184026: GO:0009914 hormone transport
GS208012: GO:0044464 cell part
GS201252: GO:0044425 membrane part
GS210212: GO:0005575 cellular_component
GS186430: GO:0007243 intracellular protein kinase cascade
GS174081: HP:0004322 Short stature
GS195291: GO:0006355 regulation of transcription, DNA-dependent
GS201239: GO:0046483 heterocycle metabolic process
GS177334: GO:0016192 vesicle-mediated transport
GS191400: GO:0010817 regulation of hormone levels
GS205369: GO:0010468 regulation of gene expression
GS192073: GO:1901576 organic substance biosynthetic process
GS185796: GO:0023061 signal release
GS188399: GO:0044238 primary metabolic process
GS173020: HP:0000818 Abnormality of the endocrine system
GS188762: GO:0009889 regulation of biosynthetic process
GS206623: GO:0050794 regulation of cellular process
GS197924: GO:0046649 lymphocyte activation
GS184435: GO:0046483 heterocycle metabolic process
GS171595: HP:0005406 Recurrent bacterial skin infections
GS169063: MP:0005432 abnormal pro-B cell morphology
GS168422: MP:0000716 abnormal immune system cell morphology
GS163818: MP:0002722 abnormal immune system organ morphology
GS166570: MP:0000694 spleen hypoplasia
GS169284: MP:0005093 decreased B cell proliferation
GS200527: GO:0002721 regulation of B cell cytokine production
GS203402: GO:0007498 mesoderm development
GS177623: GO:0002553 histamine secretion by mast cell
GS179580: GO:0036094 small molecule binding
GS194038: GO:1901362 organic cyclic compound biosynthetic process
GS201792: GO:0032559 adenyl ribonucleotide binding
GS205144: GO:0048468 cell development
GS169130: MP:0002441 abnormal granulocyte morphology
GS205623: GO:0009888 tissue development
GS176101: HP:0000924 Abnormality of the skeletal system
GS172403: HP:0011873 Abnormal platelet count
GS184220: GO:0071702 organic substance transport
GS183803: GO:0044267 cellular protein metabolic process
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
GS171791: HP:0000370 Abnormality of the middle ear
GS198022: GO:0002703 regulation of leukocyte mediated immunity
GS174385: HP:0002088 Abnormality of the lung
GS174500: HP:0000707 Abnormality of the nervous system
GS177310: GO:1901360 organic cyclic compound metabolic process
GS171998: HP:0001939 Abnormality of metabolism/homeostasis
GS203755: GO:0016265 death
GS167020: MP:0003956 abnormal body size
GS164263: MP:0002083 premature death
GS169331: MP:0001663 abnormal digestive system physiology
GS200016: GO:0001817 regulation of cytokine production
GS162986: MP:0001802 arrested B cell differentiation
GS169535: MP:0005397 hematopoietic system phenotype
GS210180: GO:0031326 regulation of cellular biosynthetic process
GS201488: GO:0021700 developmental maturation
GS166038: MP:0005351 decreased susceptibility to autoimmune disorder
GS204096: GO:0030183 B cell differentiation
GS127019: 2-Naphthylamine interacting genes (MeSH:D015081) in CTD
GS177902: GO:0042802 identical protein binding
GS182834: GO:0005623 cell
GS205622: GO:0009889 regulation of biosynthetic process
GS176087: HP:0006562 Viral hepatitis
GS191151: GO:0010556 regulation of macromolecule biosynthetic process
GS205511: GO:0001882 nucleoside binding
GS136623: Stem cell proliferation 11 (Scpro11, Published QTL Chr X)
GS169773: MP:0001845 abnormal inflammatory response
GS189460: GO:0060255 regulation of macromolecule metabolic process
GS126206: Nicotine interacting genes (MeSH:D009538) in CTD
GS178448: GO:0005634 nucleus
GS168845: MP:0002459 abnormal B cell physiology
GS199635: GO:0005622 intracellular
GS195206: GO:0002520 immune system development
GS167882: MP:0008496 decreased IgG2a level
GS180830: GO:0005547 phosphatidylinositol-3,4,5-trisphosphate binding
GS207365: GO:0005829 cytosol
GS178444: GO:0046777 protein autophosphorylation
GS188798: GO:0042493 response to drug
GS208061: GO:0010556 regulation of macromolecule biosynthetic process
GS178537: GO:0006355 regulation of transcription, DNA-dependent
GS205483: GO:0002221 pattern recognition receptor signaling pathway
GS196943: GO:0008152 metabolic process
GS163077: MP:0010274 increased organ/body region tumor incidence
GS180305: GO:0016310 phosphorylation
GS187146: GO:0044700 single organism signaling
GS209550: GO:0031982 vesicle
GS174554: HP:0002383 Encephalitis
GS173537: HP:0001872 Abnormality of thrombocytes
GS169734: MP:0002460 decreased immunoglobulin level
GS165244: MP:0010771 integument phenotype
GS174075: HP:0009121 Abnormal axial skeleton morphology
GS196941: GO:0008150 biological_process
GS164673: MP:0010296 increased hemolymphoid system tumor incidence
GS199634: GO:0005623 cell
GS207176: GO:0050865 regulation of cell activation
GS164136: MP:0000001 mammalian phenotype
GS173994: HP:0000509 Conjunctivitis
GS190893: GO:0030154 cell differentiation
GS169908: MP:0001601 abnormal myelopoiesis
GS166564: MP:0000692 small spleen
GS197009: GO:0005886 plasma membrane
GS187045: GO:0016070 RNA metabolic process
GS198019: GO:0002706 regulation of lymphocyte mediated immunity
GS172617: HP:0004313 Hypogammaglobulinemia
GS175814: HP:0011024 Abnormality of the gastrointestinal tract
GS204007: GO:0044700 single organism signaling
GS210182: GO:0031323 regulation of cellular metabolic process
GS163026: MP:0000221 decreased leukocyte cell number
GS196282: GO:0012501 programmed cell death
GS201431: GO:0005515 protein binding
GS163817: MP:0002359 abnormal spleen germinal center morphology
GS176613: HP:0000271 Abnormality of the face
GS165615: MP:0002123 abnormal hematopoiesis
GS188061: GO:0016772 transferase activity, transferring phosphorus-containing groups
GS196933: GO:0065009 regulation of molecular function
GS203649: GO:0030554 adenyl nucleotide binding
GS206192: GO:0048583 regulation of response to stimulus
GS176735: HP:0010929 Abnormality of cation homeostasis
GS209411: GO:0048869 cellular developmental process
GS190027: GO:0006952 defense response
GS172887: HP:0100533 Inflammatory abnormality of the eye
GS187160: GO:0044707 single-multicellular organism process
GS163314: MP:0005005 abnormal self tolerance
GS177761: GO:0044271 cellular nitrogen compound biosynthetic process
GS163851: MP:0001545 abnormal hematopoietic system physiology
GS175016: HP:0001626 Abnormality of the cardiovascular system
GS203371: GO:0002684 positive regulation of immune system process
GS185925: GO:0015893 drug transport
GS166066: MP:0009334 abnormal splenocyte proliferation
GS197355: GO:0050778 positive regulation of immune response
GS168551: MP:0002429 abnormal blood cell morphology/development
GS186881: GO:0002532 production of molecular mediator involved in inflammatory response
GS166518: MP:0008190 decreased transitional stage B cell number
GS169906: MP:0001602 impaired myelopoiesis
GS194685: GO:0050853 B cell receptor signaling pathway
GS206273: GO:0002755 MyD88-dependent toll-like receptor signaling pathway
GS168560: MP:0002420 abnormal adaptive immunity
GS209564: GO:0043231 intracellular membrane-bounded organelle
GS169846: MP:0009788 increased susceptibility to bacterial infection induced morbidity/mortality
GS172542: HP:0000830 Anterior hypopituitarism
GS202080: GO:0051252 regulation of RNA metabolic process
GS208051: GO:0002521 leukocyte differentiation
GS171274: HP:0100543 Cognitive impairment
GS207675: GO:0002696 positive regulation of leukocyte activation
GS169827: MP:0005387 immune system phenotype
GS175981: HP:0000163 Abnormality of the oral cavity
GS184976: GO:0032559 adenyl ribonucleotide binding
GS186899: GO:0016265 death
GS173262: HP:0000864 Abnormality of the hypothalamus-pituitary axis
GS171848: HP:0000598 Abnormality of the ear
GS163143: MP:0009548 abnormal platelet aggregation
GS163297: MP:0000217 abnormal leukocyte cell number
GS175015: HP:0001627 Abnormality of the heart
GS187876: GO:0045121 membrane raft
GS204021: GO:0044707 single-multicellular organism process
GS205047: GO:0006807 nitrogen compound metabolic process
GS184629: GO:0005515 protein binding
GS208665: GO:0008289 lipid binding
GS176186: HP:0000079 Abnormality of the urinary system
GS166201: MP:0008186 increased pro-B cell number
GS177843: GO:0002376 immune system process
GS165258: MP:0008537 increased susceptibility to induced colitis
GS192539: GO:0006955 immune response
GS163142: MP:0009549 decreased platelet aggregation
GS168118: MP:0001191 abnormal skin condition
GS197139: GO:0002429 immune response-activating cell surface receptor signaling pathway
GS194645: GO:0042802 identical protein binding
GS172024: HP:0001369 Arthritis
GS198025: GO:0002700 regulation of production of molecular mediator of immune response
GS179211: GO:0007154 cell communication
GS171067: HP:0002664 Neoplasm
GS173327: HP:0005368 Abnormality of humoral immunity
GS188465: GO:0031410 cytoplasmic vesicle
GS192265: GO:0007165 signal transduction
GS166064: MP:0009336 increased splenocyte proliferation
GS180152: GO:0065007 biological regulation
GS185881: GO:0035639 purine ribonucleoside triphosphate binding
GS165536: MP:0005371 limbs/digits/tail phenotype
GS203303: GO:0045579 positive regulation of B cell differentiation
GS163640: MP:0009787 increased susceptibility to infection induced morbidity/mortality
GS165397: MP:0001265 decreased body size
GS170601: MP:0005621 abnormal cell physiology
GS179464: GO:0001821 histamine secretion
GS169485: MP:0000726 absent lymphocyte
GS171789: HP:0001392 Abnormality of the liver
GS173267: HP:0004432 Agammaglobulinemia
GS189544: GO:0002448 mast cell mediated immunity
GS187293: GO:0009611 response to wounding
GS194284: GO:0048534 hematopoietic or lymphoid organ development
GS172030: HP:0000365 Hearing impairment
GS202716: GO:0035639 purine ribonucleoside triphosphate binding
GS172021: HP:0001367 Abnormal joint morphology
GS173423: HP:0004429 Recurrent viral infections
GS196806: GO:0032502 developmental process
GS206618: GO:0050793 regulation of developmental process
GS163642: MP:0009785 altered susceptibility to infection induced morbidity/mortality
GS166215: MP:0008188 abnormal transitional stage B cell morphology
GS189549: GO:0002443 leukocyte mediated immunity
GS170965: HP:0000153 Abnormality of the mouth
GS203594: GO:0043226 organelle
GS200432: GO:0002682 regulation of immune system process
GS205364: GO:0010467 gene expression
GS208734: GO:0016740 transferase activity
GS194172: GO:0006915 apoptotic process
GS200446: GO:0017076 purine nucleotide binding
GS167719: MP:0002816 colitis
GS178744: GO:0007249 I-kappaB kinase/NF-kappaB cascade
GS210002: GO:0044444 cytoplasmic part
GS171168: HP:0000234 Abnormality of the head
GS179822: GO:0006468 protein phosphorylation
GS164022: MP:0008246 abnormal leukocyte morphology
GS175530: HP:0000002 Abnormality of body height
GS194586: GO:0002376 immune system process
GS209009: GO:1901576 organic substance biosynthetic process
GS190949: GO:0009058 biosynthetic process
GS184983: GO:0032550 purine ribonucleoside binding
GS165537: MP:0005376 homeostasis/metabolism phenotype
GS173694: HP:0001648 Cor pulmonale
GS135733: dietary obesity 7 (Dob7, Published QTL Chr X)
GS204036: GO:0045321 leukocyte activation
GS174331: HP:0002715 Abnormality of the immune system
GS205480: GO:0002224 toll-like receptor signaling pathway
GS192174: GO:0000166 nucleotide binding
GS203593: GO:0043227 membrane-bounded organelle
GS171346: HP:0002846 Abnormality of B cells
GS177308: GO:1901362 organic cyclic compound biosynthetic process
GS127127: Benzo(a)pyrene interacting genes (MeSH:D001564) in CTD
GS189231: GO:0002263 cell activation involved in immune response
GS197623: GO:0005547 phosphatidylinositol-3,4,5-trisphosphate binding
GS168844: MP:0002458 abnormal B cell number
GS184144: GO:0045117 azole transport
GS170545: MP:0002022 increased lymphoma incidence
GS194605: GO:0001775 cell activation
GS174131: HP:0002011 Abnormality of the central nervous system
GS202316: GO:0050789 regulation of biological process
GS194087: GO:0003674 molecular_function
GS206111: GO:0097285 cell-type specific apoptotic process
GS165937: MP:0008737 abnormal spleen physiology
GS191268: GO:0010033 response to organic substance
GS165242: MP:0008214 increased immature B cell number
GS166560: MP:0008497 decreased IgG2b level
GS167098: MP:0001819 abnormal immune cell physiology
GS171898: HP:0011450 CNS infection
GS177356: GO:0003674 molecular_function
GS203590: GO:0043229 intracellular organelle
GS189312: GO:0043299 leukocyte degranulation
GS199032: GO:0036211 protein modification process
GS167321: MP:0003945 abnormal lymphocyte physiology
GS171313: HP:0003139 Panhypogammaglobulinemia
GS175750: HP:0000010 Recurrent urinary tract infections
GS177309: GO:1901363 heterocyclic compound binding
GS198285: GO:0004672 protein kinase activity
GS167708: MP:0002412 increased susceptibility to bacterial infection
GS175119: HP:0001881 Abnormality of leukocytes
GS164308: MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis
GS168970: MP:0008212 absent mature B cells
GS185544: GO:0006979 response to oxidative stress
GS206277: GO:0002757 immune response-activating signal transduction
GS188410: GO:0032774 RNA biosynthetic process
GS192471: GO:0048869 cellular developmental process
GS194336: GO:0043412 macromolecule modification
GS167551: MP:0008498 decreased IgG3 level
GS180166: GO:0008152 metabolic process
GS171832: HP:0000118 Phenotypic abnormality
GS203886: GO:1901265 nucleoside phosphate binding
GS182740: GO:0018193 peptidyl-amino acid modification
GS203072: GO:0090304 nucleic acid metabolic process
GS166059: MP:0009339 decreased splenocyte number
GS170362: MP:0000717 abnormal lymphocyte cell number
GS177382: GO:0097159 organic cyclic compound binding
GS166062: MP:0009333 abnormal splenocyte physiology
GS193056: GO:0051608 histamine transport
GS174337: HP:0002718 Recurrent bacterial infections
GS192509: GO:0006810 transport
GS166862: MP:0000689 abnormal spleen morphology
GS175524: HP:0000009 Functional abnormality of the bladder
GS202077: GO:0051251 positive regulation of lymphocyte activation
GS206909: GO:0006952 defense response
GS167545: MP:0001793 altered susceptibility to infection
GS184978: GO:0032555 purine ribonucleotide binding
GS205604: GO:0002764 immune response-regulating signaling pathway
GS172118: HP:0004332 Abnormality of lymphocytes
GS168848: MP:0002452 abnormal antigen presenting cell physiology
GS194872: GO:0004715 non-membrane spanning protein tyrosine kinase activity
GS170413: MP:0008071 absent B cells
GS172286: HP:0000824 Growth hormone deficiency
GS175754: HP:0000014 Abnormality of the bladder
GS190714: GO:0016020 membrane
GS167431: MP:0008523 absent lymph node germinal center
GS187751: GO:0019222 regulation of metabolic process
GS165422: MP:0002494 increased IgM level
GS209480: GO:0006955 immune response
GS188322: GO:0005524 ATP binding
GS195214: GO:0009987 cellular process
GS207177: GO:0050864 regulation of B cell activation
GS163934: MP:0001764 abnormal homeostasis
GS204204: GO:0006351 transcription, DNA-dependent
GS180034: GO:0032502 developmental process
GS201729: GO:0002253 activation of immune response
GS175128: HP:0011123 Inflammatory abnormality of the skin
GS199124: GO:0051716 cellular response to stimulus
GS200648: GO:0044260 cellular macromolecule metabolic process
GS167440: MP:0000334 decreased granulocyte number
GS165525: MP:0010768 mortality/aging
GS193639: GO:0051641 cellular localization
GS201794: GO:0032555 purine ribonucleotide binding
GS169025: MP:0001657 abnormal induced morbidity/mortality
GS203392: GO:0035091 phosphatidylinositol binding
GS184684: GO:0021700 developmental maturation
GS185259: GO:0051252 regulation of RNA metabolic process
GS203642: GO:0006725 cellular aromatic compound metabolic process
GS194683: GO:0050851 antigen receptor-mediated signaling pathway
GS174335: HP:0001871 Abnormality of blood and blood-forming tissues
GS175714: HP:0011389 Functional abnormality of the inner ear
GS207923: GO:0034641 cellular nitrogen compound metabolic process
GS187023: GO:1901265 nucleoside phosphate binding
GS198483: GO:0034142 toll-like receptor 4 signaling pathway
GS165265: MP:0005014 increased B cell number
GS192296: GO:0006796 phosphate-containing compound metabolic process
GS198263: GO:0005488 binding
GS205145: GO:0048469 cell maturation
GS194040: GO:1901360 organic cyclic compound metabolic process
GS171527: HP:0001707 Abnormality of the right ventricle
GS206355: GO:0023052 signaling
GS170544: MP:0002023 B cell derived lymphoma
GS192918: GO:0050896 response to stimulus
GS175431: HP:0011122 Abnormality of skin physiology
GS210424: GO:0045619 regulation of lymphocyte differentiation
GS186798: GO:0030554 adenyl nucleotide binding
GS190067: GO:0018130 heterocycle biosynthetic process
GS165524: MP:0010769 abnormal survival
GS170971: HP:0000407 Sensorineural hearing impairment
GS175423: HP:0010461 Abnormality of the male genitalia
GS163609: MP:0008781 abnormal B cell apoptosis
GS171559: HP:0000388 Otitis media
GS162989: MP:0001806 decreased IgM level
GS209235: GO:0006793 phosphorus metabolic process
GS203306: GO:0045577 regulation of B cell differentiation
GS205266: GO:0032774 RNA biosynthetic process
GS195977: GO:0007154 cell communication
GS206418: GO:0002443 leukocyte mediated immunity
GS170617: MP:0005022 abnormal immature B cell morphology
GS186982: GO:0018212 peptidyl-tyrosine modification
GS165742: MP:0008472 abnormal spleen secondary B follicle morphology
GS194023: GO:2000106 regulation of leukocyte apoptotic process
GS194905: GO:0008219 cell death
GS194267: GO:0043170 macromolecule metabolic process
GS198274: GO:0035556 intracellular signal transduction
GS210357: GO:0044249 cellular biosynthetic process
GS180452: GO:0044237 cellular metabolic process
GS174136: HP:0002014 Diarrhea
GS201106: GO:0002218 activation of innate immune response
GS204735: GO:0045121 membrane raft
GS173538: HP:0001873 Thrombocytopenia
GS167717: MP:0002419 abnormal innate immunity
GS206953: GO:0018130 heterocycle biosynthetic process
GS203057: GO:0048518 positive regulation of biological process
GS167589: MP:0005016 decreased lymphocyte cell number
GS188288: GO:0048469 cell maturation
GS170858: HP:0002901 Hypocalcemia
GS174453: HP:0001438 Abnormality of the abdomen
GS194499: GO:0044271 cellular nitrogen compound biosynthetic process
GS180164: GO:0008150 biological_process
GS168995: MP:0009642 abnormal blood homeostasis
GS177531: GO:0043170 macromolecule metabolic process
GS188287: GO:0048468 cell development
GS173962: HP:0001581 Recurrent skin infections
GS175765: HP:0001419 X-linked recessive inheritance
GS196986: GO:0045597 positive regulation of cell differentiation
GS206415: GO:0002440 production of molecular mediator of immune response
GS205179: GO:0005524 ATP binding
GS205255: GO:0044238 primary metabolic process
GS170479: MP:0008522 abnormal lymph node germinal center morphology
GS171833: HP:0000119 Abnormality of the genitourinary system
GS167575: MP:0005013 increased lymphocyte cell number
GS169917: MP:0010155 abnormal intestine physiology
GS191090: GO:0004713 protein tyrosine kinase activity
GS167987: MP:0003132 increased pre-B cell number
GS181483: GO:0035556 intracellular signal transduction
GS197588: GO:0070228 regulation of lymphocyte apoptotic process
GS170081: MP:0001858 intestinal inflammation
GS175136: HP:0000024 Prostatitis
GS207858: GO:0009059 macromolecule biosynthetic process
GS209232: GO:0006796 phosphate-containing compound metabolic process
GS177721: GO:0051234 establishment of localization
GS186460: GO:0045576 mast cell activation
GS165417: MP:0002493 increased IgG level
GS209455: GO:0003824 catalytic activity
GS184218: GO:0071704 organic substance metabolic process
GS164605: MP:0002339 abnormal lymph node morphology
GS200602: GO:0044267 cellular protein metabolic process
GS163568: MP:0002551 abnormal blood coagulation
GS169700: MP:0004940 abnormal B-1 B cell morphology
GS193563: GO:0006950 response to stress
GS126769: Calcium interacting genes (MeSH:D002118) in CTD
GS183514: GO:0019219 regulation of nucleobase-containing compound metabolic process
GS866: Linear decrease in expression in both Pax6 (Sey) mutants and controls.
GS183848: GO:0044260 cellular macromolecule metabolic process
GS186757: GO:0034654 nucleobase-containing compound biosynthetic process
GS169304: MP:0008251 abnormal phagocyte morphology
GS174646: HP:0000951 Abnormality of the skin
GS170573: MP:0004976 abnormal B-1 B cell number
GS193549: GO:0002275 myeloid cell activation involved in immune response
GS181493: GO:0004672 protein kinase activity
GS170651: MP:0002344 abnormal lymph node B cell domain morphology
GS198685: GO:0048522 positive regulation of cellular process
GS191266: GO:0010035 response to inorganic substance
GS201949: GO:0044699 single-organism process
GS208954: GO:0006139 nucleobase-containing compound metabolic process
GS200015: GO:0001816 cytokine production
GS202902: GO:0050871 positive regulation of B cell activation
GS184583: GO:0043303 mast cell degranulation
GS188641: GO:0071944 cell periphery
GS168086: MP:0000172 abnormal bone marrow cell number
GS193874: GO:0018108 peptidyl-tyrosine phosphorylation
GS190950: GO:0009059 macromolecule biosynthetic process
GS178461: GO:0009987 cellular process
GS189550: GO:0002444 myeloid leukocyte mediated immunity
GS193061: GO:0044444 cytoplasmic part
GS192624: GO:0043231 intracellular membrane-bounded organelle
GS186743: GO:0043227 membrane-bounded organelle
GS192041: GO:0043169 cation binding
GS171901: HP:0010985 Gonosomal inheritance
GS210507: GO:0006950 response to stress
GS173384: HP:0002750 Delayed skeletal maturation
GS174372: HP:0002024 Malabsorption
GS162984: MP:0001800 abnormal humoral immune response
GS169973: MP:0002006 tumorigenesis
GS187033: GO:0006887 exocytosis
GS203276: GO:0007243 intracellular protein kinase cascade
GS179830: GO:0006464 cellular protein modification process
GS201728: GO:0002250 adaptive immune response
GS193268: GO:0005575 cellular_component
GS194039: GO:1901363 heterocyclic compound binding
GS188190: GO:0006807 nitrogen compound metabolic process
GS184217: GO:0071705 nitrogen compound transport
GS193151: GO:0032940 secretion by cell
GS199019: GO:0002367 cytokine production involved in immune response
GS209215: GO:0007166 cell surface receptor signaling pathway
GS207797: GO:0030154 cell differentiation
GS207581: GO:0007275 multicellular organismal development
GS172358: HP:0003117 Abnormality of circulating hormone level
GS171902: HP:0010987 Abnormality of cellular immune system
GS171452: HP:0008775 Abnormality of the prostate
GS176718: HP:0000078 Abnormality of the genital system
GS176817: HP:0011446 Abnormality of higher mental function
GS205002: GO:0048856 anatomical structure development
GS170931: HP:0001287 Meningitis
GS197443: GO:0032549 ribonucleoside binding
GS173335: HP:0004363 Abnormality of calcium homeostasis
GS163263: MP:0003762 abnormal immune organ physiology
GS166746: MP:0002224 abnormal spleen size
GS174494: HP:0002564 Malformation of the heart and great vessels
GS173014: HP:0010936 Abnormality of the lower urinary tract
GS201730: GO:0002252 immune effector process
GS207857: GO:0009058 biosynthetic process
GS163956: MP:0011180 abnormal hematopoietic cell number
GS206191: GO:0048584 positive regulation of response to stimulus
GS201023: GO:0071704 organic substance metabolic process
GS196595: GO:0006464 cellular protein modification process
GS166706: MP:0002166 altered tumor susceptibility
GS171893: HP:0011458 Abdominal symptom
GS184566: GO:0019538 protein metabolic process
GS170964: HP:0000152 Abnormality of head and neck
GS175260: HP:0002732 Lymph node hypoplasia
GS191106: GO:0044464 cell part
GS173290: HP:0011354 Generalized abnormality of skin
GS178123: GO:0004715 non-membrane spanning protein tyrosine kinase activity
GS179517: GO:0012501 programmed cell death
GS206020: GO:0045621 positive regulation of lymphocyte differentiation
GS167997: MP:0002406 increased susceptibility to infection
GS186227: GO:0090304 nucleic acid metabolic process
GS172031: HP:0000364 Hearing abnormality
GS167991: MP:0002401 abnormal lymphopoiesis
GS204612: GO:0019222 regulation of metabolic process
GS210168: GO:0030098 lymphocyte differentiation
GS172416: HP:0002242 Abnormality of the intestine
GS181533: GO:0046872 metal ion binding
GS162887: MP:0006043 decreased apoptosis
GS163857: MP:0005065 abnormal neutrophil morphology
GS166065: MP:0009337 abnormal splenocyte number
GS165421: MP:0002497 increased IgE level
GS177862: GO:0001775 cell activation
GS170460: MP:0008217 abnormal B cell activation
GS195502: GO:0007249 I-kappaB kinase/NF-kappaB cascade
GS204819: GO:0002819 regulation of adaptive immune response
GS200844: GO:0031347 regulation of defense response
GS164133: MP:0005076 abnormal cell differentiation
GS170748: MP:0005025 abnormal response to infection
GS168563: MP:0002425 altered susceptibility to autoimmune disorder
GS165024: MP:0008203 absent B-1a cells
GS169133: MP:0002442 abnormal leukocyte physiology
GS203607: GO:0034654 nucleobase-containing compound biosynthetic process
GS178155: GO:0008219 cell death
GS168710: MP:0001648 abnormal apoptosis
GS185585: GO:0044710 single-organism metabolic process
GS173137: HP:0011821 Abnormality of facial skeleton
GS193632: GO:0051649 establishment of localization in cell
GS162990: MP:0001807 decreased IgA level
GS208978: GO:0043169 cation binding
GS197349: GO:0050776 regulation of immune response
GS203735: GO:0019932 second-messenger-mediated signaling
GS176632: HP:0001903 Anemia
GS189388: GO:0016301 kinase activity
GS201800: GO:0032553 ribonucleotide binding
GS195539: GO:0045089 positive regulation of innate immune response
GS164630: MP:0006298 abnormal platelet activation
GS205338: GO:0051094 positive regulation of developmental process
GS173990: HP:0000502 Abnormality of the conjunctiva
GS188651: GO:0001883 purine nucleoside binding
GS180156: GO:0065008 regulation of biological quality
GS189484: GO:0023052 signaling
GS208128: GO:0045088 regulation of innate immune response
GS202415: GO:0044710 single-organism metabolic process
GS206544: GO:2000112 regulation of cellular macromolecule biosynthetic process
GS169832: MP:0005381 digestive/alimentary phenotype
GS194133: GO:0005737 cytoplasm
GS165474: MP:0002723 abnormal immune serum protein physiology
GS167627: MP:0005460 abnormal leukopoiesis
GS194669: GO:0034134 toll-like receptor 2 signaling pathway
GS175265: HP:0002733 Abnormality of the lymph nodes
GS189860: GO:0043167 ion binding
GS200837: GO:0031349 positive regulation of defense response
GS206329: GO:0060255 regulation of macromolecule metabolic process
GS195199: GO:0005634 nucleus
GS171752: HP:0001713 Abnormality of cardiac ventricle
GS191796: GO:0016740 transferase activity
GS162988: MP:0001805 decreased IgG level
GS189240: GO:2001141 regulation of RNA biosynthetic process
GS165386: MP:0001262 decreased body weight
GS170020: MP:0008215 decreased immature B cell number
GS208914: GO:0051091 positive regulation of sequence-specific DNA binding transcription factor activity
GS180021: GO:0046903 secretion
GS169774: MP:0001846 increased inflammatory response
GS182325: GO:0051716 cellular response to stimulus
GS185492: GO:0050789 regulation of biological process
GS172364: HP:0003111 Abnormality of ion homeostasis
GS170646: MP:0002343 abnormal lymph node cortex morphology
GS167714: MP:0002414 abnormal myeloblast morphology/development
GS164790: MP:0008172 abnormal follicular B cell morphology
GS205332: GO:0051092 positive regulation of NF-kappaB transcription factor activity
GS136883: testis weight (Tswt, Published QTL Chr X)
GS192609: GO:0031982 vesicle